Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric Ependymoma.

Daryani VM, Patel YT, Tagen M, Turner DC, Carcaboso AM, Atkinson JM, Gajjar A, Gilbertson RJ, Wright KD, Stewart CF.

CPT Pharmacometrics Syst Pharmacol. 2016 Apr 14. doi: 10.1002/psp4.12075. [Epub ahead of print]

2.

The Similarities and Differences between Intracranial and Spinal Ependymomas : A Review from a Genetic Research Perspective.

Lee CH, Chung CK, Ohn JH, Kim CH.

J Korean Neurosurg Soc. 2016 Mar;59(2):83-90. doi: 10.3340/jkns.2016.59.2.83. Epub 2016 Feb 29. Review.

3.

IsoSeq analysis and functional annotation of the infratentorial ependymoma tumor tissue on PacBio RSII platform.

Singh N, Sahu DK, Chowdhry R, Mishra A, Goel MM, Faheem M, Srivastava C, Ojha BK, Gupta DK, Kant R.

Meta Gene. 2015 Nov 23;7:70-5. doi: 10.1016/j.mgene.2015.11.004. eCollection 2016 Feb.

4.

The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity.

Vo BT, Wolf E, Kawauchi D, Gebhardt A, Rehg JE, Finkelstein D, Walz S, Murphy BL, Youn YH, Han YG, Eilers M, Roussel MF.

Cancer Cell. 2016 Jan 11;29(1):5-16. doi: 10.1016/j.ccell.2015.12.003.

PMID:
26766587
5.

Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma.

Wright KD, Daryani VM, Turner DC, Onar-Thomas A, Boulos N, Orr BA, Gilbertson RJ, Stewart CF, Gajjar A.

Neuro Oncol. 2015 Dec;17(12):1620-7. doi: 10.1093/neuonc/nov181. Epub 2015 Nov 4.

PMID:
26541630
6.

Overcoming Chemoresistance of Pediatric Ependymoma by Inhibition of STAT3 Signaling.

Phi JH, Choi SA, Kim SK, Wang KC, Lee JY, Kim DG.

Transl Oncol. 2015 Oct;8(5):376-86. doi: 10.1016/j.tranon.2015.08.001.

7.

Water Channels Aquaporin 4 and -1 Expression in Subependymoma Depends on the Localization of the Tumors.

Noell S, Fallier-Becker P, Mack AF, Hoffmeister M, Beschorner R, Ritz R.

PLoS One. 2015 Jun 26;10(6):e0131367. doi: 10.1371/journal.pone.0131367. eCollection 2015.

8.

MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours.

Garg N, Vijayakumar T, Bakhshinyan D, Venugopal C, Singh SK.

Stem Cells Int. 2015;2015:141793. doi: 10.1155/2015/141793. Epub 2015 May 3. Review.

9.

An integrative view on sex differences in brain tumors.

Sun T, Plutynski A, Ward S, Rubin JB.

Cell Mol Life Sci. 2015 Sep;72(17):3323-42. doi: 10.1007/s00018-015-1930-2. Epub 2015 May 19. Review.

10.

Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies.

Ediriwickrema A, Saltzman WM.

ACS Biomater Sci Eng. 2015 Feb 9;1(2):64-78. Epub 2015 Jan 13. Review.

11.

Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.

Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, Wani K, Tatevossian R, Punchihewa C, Johann P, Reimand J, Warnatz HJ, Ryzhova M, Mack S, Ramaswamy V, Capper D, Schweizer L, Sieber L, Wittmann A, Huang Z, van Sluis P, Volckmann R, Koster J, Versteeg R, Fults D, Toledano H, Avigad S, Hoffman LM, Donson AM, Foreman N, Hewer E, Zitterbart K, Gilbert M, Armstrong TS, Gupta N, Allen JC, Karajannis MA, Zagzag D, Hasselblatt M, Kulozik AE, Witt O, Collins VP, von Hoff K, Rutkowski S, Pietsch T, Bader G, Yaspo ML, von Deimling A, Lichter P, Taylor MD, Gilbertson R, Ellison DW, Aldape K, Korshunov A, Kool M, Pfister SM.

Cancer Cell. 2015 May 11;27(5):728-43. doi: 10.1016/j.ccell.2015.04.002.

12.

Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype.

Mack SC, Agnihotri S, Bertrand KC, Wang X, Shih DJ, Witt H, Hill N, Zayne K, Barszczyk M, Ramaswamy V, Remke M, Thompson Y, Ryzhova M, Massimi L, Grajkowska W, Lach B, Gupta N, Weiss WA, Guha A, Hawkins C, Croul S, Rutka JT, Pfister SM, Korshunov A, Pekmezci M, Tihan T, Philips JJ, Jabado N, Zadeh G, Taylor MD.

Clin Cancer Res. 2015 Aug 15;21(16):3750-8. doi: 10.1158/1078-0432.CCR-14-2650. Epub 2015 May 8.

PMID:
25957288
13.

Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.

Hoffman LM, Fouladi M, Olson J, Daryani VM, Stewart CF, Wetmore C, Kocak M, Onar-Thomas A, Wagner L, Gururangan S, Packer RJ, Blaney SM, Gajjar A, Kun LE, Boyett JM, Gilbertson RJ.

Childs Nerv Syst. 2015 Aug;31(8):1283-9. doi: 10.1007/s00381-015-2725-3. Epub 2015 May 1.

14.

Expression alterations define unique molecular characteristics of spinal ependymomas.

Lourdusamy A, Rahman R, Grundy RG.

Oncotarget. 2015 Aug 14;6(23):19780-91.

15.

The ependymal region of the adult human spinal cord differs from other species and shows ependymoma-like features.

Garcia-Ovejero D, Arevalo-Martin A, Paniagua-Torija B, Florensa-Vila J, Ferrer I, Grassner L, Molina-Holgado E.

Brain. 2015 Jun;138(Pt 6):1583-97. doi: 10.1093/brain/awv089. Epub 2015 Apr 15.

PMID:
25882650
16.

A mouse model of human primitive neuroectodermal tumors resulting from microenvironmentally-driven malignant transformation of orthotopically transplanted radial glial cells.

Malchenko S, Sredni ST, Hashimoto H, Kasai A, Nagayasu K, Xie J, Margaryan NV, Seiriki K, Lulla RR, Seftor RE, Pachman LM, Meltzer HY, Hendrix MJ, Soares MB.

PLoS One. 2015 Mar 31;10(3):e0121707. doi: 10.1371/journal.pone.0121707. eCollection 2015.

17.

EphB2 activation is required for ependymoma development as well as inhibits differentiation and promotes proliferation of the transformed cell.

Chen P, Rossi N, Priddy S, Pierson CR, Studebaker AW, Johnson RA.

Sci Rep. 2015 Mar 24;5:9248. doi: 10.1038/srep09248.

18.

Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?

Olsen TK, Panagopoulos I, Meling TR, Micci F, Gorunova L, Thorsen J, Due-T√łnnessen B, Scheie D, Lund-Iversen M, Krossnes B, Saxhaug C, Heim S, Brandal P.

Neuro Oncol. 2015 Oct;17(10):1365-73. doi: 10.1093/neuonc/nov039. Epub 2015 Mar 19.

PMID:
25795305
19.

NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma.

Georgescu MM, Yell P, Mobley BC, Shang P, Georgescu T, Wang SH, Canoll P, Hatanpaa KJ, White CL 3rd, Raisanen JM.

Acta Neuropathol Commun. 2015 Mar 8;3:11. doi: 10.1186/s40478-015-0197-z.

20.

Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.

Chen YH, McGowan LD, Cimino PJ, Dahiya S, Leonard JR, Lee da Y, Gutmann DH.

Cell Rep. 2015 Mar 24;10(11):1899-912. doi: 10.1016/j.celrep.2015.02.041. Epub 2015 Mar 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk